Importantly, PTBP1 expression was significantly increased in the livers of patients with fibrosis and metabolic dysfunction-associated steatohepatitis (MASH, previously known as NASH) compared to normal or steatotic individuals. The gene discussed is PTBP1; the disease is metabolic dysfunction-associated steatohepatitis.